---
title: "United Therapeutics Q2 26 Earnings Conference Call At 9:00 AM ET"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294962964.md"
description: "Add as your preferred news source on Google Add Now United Therapeutics Corp (UTHR) will host a conference call at 09:00 AM ET on Aug 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to For comments and feedback contact: editorial@rttnews.comBusiness News"
datetime: "2026-08-05T12:02:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294962964.md)
  - [en](https://longbridge.com/en/news/294962964.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294962964.md)
generator: "portal-rs"
---

# United Therapeutics Q2 26 Earnings Conference Call At 9:00 AM ET

Add  as your preferred news source on Google

 Add Now

United Therapeutics Corp (UTHR) will host a conference call at 09:00 AM ET on Aug 5, 2026, to discuss Q2 26 earnings results. 

To access the live webcast, log on to https://ir.unither.com/events-and-presentations 

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [United Therapeutics (NASDAQ:UTHR)  Shares Down 4.7%  on Insider Selling](https://longbridge.com/en/news/297807755.md)
- [United Therapeutics says FDA accepts Tyvaso sNDA for idiopathic pulmonary fibrosis review](https://longbridge.com/en/news/297773723.md)
- [United Therapeutics (NASDAQ:UTHR) CEO Sells $4,914,160.00 in Stock](https://longbridge.com/en/news/297307258.md)
- [United Therapeutics submits FDA NDA for PAH drug ralinepag](https://longbridge.com/en/news/297312776.md)
- [United Therapeutics Chairperson, CEO Rothblatt sells 9,500 shares for $4.92 million](https://longbridge.com/en/news/297085883.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**